INSY Profile
Insys
Therapeutics, Inc. (INSY) is a pharmaceutical company that focuses on
developing and commercializing products that address serious medical
needs, particularly in pain management. The company was founded in
1990 and is headquartered in Chandler, Arizona.
Insys has
developed a number of products, including Subsys, a sublingual
fentanyl spray used to manage breakthrough cancer pain in adult
patients. The company has alo developed a variety of generic drugs, as
well as branded pharmaceuticals that are designed to target specific
medical conditions.
Insys has faced controversy in recent
years, particularly related to the marketing of Subsys. In 2019, the
company agreed to pay $225 million to settle criminal and civil
charges related to its marketing practices. The charges included
allegations that Insys had bribed doctors to prescribe Subsys and had
misled insurance companies about the need fo
|
